Eye drops, ointments sold at Walgreens recalled

(HealthDay)—A number of over-the-counter eye products sold at Walgreens have been recalled by manufacturer

Adding bevacizumab improves overall survival in NSCLC

(HealthDay)—The addition of bevacizumab to carboplatin/pemetrexed is associated with improved overall survival among patients

Topical cream shows promise in treatment of skin pigmentation disease, vitiligo

A nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston,

Counterfeit medicine a ‘growing threat’: EU study

Counterfeit medicine is a “growing threat” in Europe, causing serious illness or even death

Naloxone access law in Pennsylvania falls short

A new study from researchers at the University of Illinois at Chicago finds that

Expert urges cautious approach to ketamine use

Physicians and patients are excited about ketamine, the latest drug to treat depression, but

Studying implications of policy and law for treatment of substance use disorders

People who suffer from substance use disorder need effective treatments, however, 90 percent of

Most preventive antibiotics prescribed by dentists are unnecessary

A new study conducted by researchers at the University of Illinois at Chicago and

Researchers finds new RX target for common STD

Research led by Ashok Aiyar, Ph.D., Associate Professor of Microbiology, Immunology and Parasitology at

Daratumumab cuts risk for progression in multiple myeloma

(HealthDay)—For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and

FDA approves $2M medicine, most expensive ever

U.S. regulators have approved the most expensive medicine ever, for a rare disorder that

U.S. lawmakers say WHO opioid guidelines too lax

The World Health Organization’s pain care guidelines contain false claims about the safety of

Medication nonadherence common in patients with T2DM

(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with

As more veterans die of opioid overdoses, study shows need to focus beyond prescriptions

A dramatic rise in opioid overdose deaths among American veterans in recent years has

Rising prescription drug costs continue to create tough choices for seniors

(HealthDay)—A solid minority of senior citizens still struggles to afford their prescription medications, a

Avelumab and axitinib approved for treatment of renal cell carcinoma

(HealthDay)—Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma

Americans’ prescription med use is declining

(HealthDay)—Bucking a longstanding upward trend, new data shows that the percentage of Americans taking

Drug overdoses in young people on the rise

In American adolescents and young adults, death rates from drug poisoning, particularly from opioids,

Researchers engineer a cost-effective treatment for neglected tropical disease

Researchers have turned a fungus into a disease-curing factory through modern genetic engineering and

Over-the-counter meds save health care system money

(HealthDay)—On average, each dollar spent on over-the-counter (OTC) medicines saves the U.S. health care

FDA warns homeopathic company about illegal product claims

(HealthDay)—Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with

Widespread and possibly risky use of herbal medicines among pregnant women in Ethiopia

A study of Ethiopian women’s use of traditional medicinal plants during pregnancy has come

Two for the price of one: Mechanistic insights lead to drug repositioning

Lung adenocarcinoma is the most common type of lung cancer. Although various targeted drugs

FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection

KENILWORTH, N.J.–(BUSINESS WIRE) February 19, 2019 –Merck (NYSE: MRK), known as MSD outside the

Monthly buprenorphine injections effective for opioid use disorders

A newly published study suggests the long-acting buprenorphine formulation BUP-XR is more effective than

Research reveals need to ensure drug trials for anxiety are carried out on appropriate patients

University of Otago psychiatry experts are concerned some medications used to treat anxiety may

Merck Receives Breakthrough Therapy Designation from FDA for V114, the Company’s Investigational 15-Valent Conjugate Vaccine for the Prevention of Invasive Pneumococcal Disease, in Infants, Children, and Adolescents

KENILWORTH, N.J.–(BUSINESS WIRE) January 30, 2019 –Merck (NYSE: MRK), known as MSD outside of

Advances in the study of drugs to combat cognitive impairment in schizophrenia

A study by the UPV/EHU has assessed whether drugs used to delay cognitive deterioration

GPs prescribe more opioids for pain in poor Northern areas, study reveals

English patients living in poorer areas are likely to be prescribed more opioids by

The opioid crisis: What we should learn from the AIDS epidemic

There are important lessons to be learned from the successes and failures of the